Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
1 Year
—
-23.32%
Shrank
—
—
Shrank
—
1 Year
Score—
Net Growth-23.32%
Net TrendShrank
Net Income Consistency—
Rev Growth—
Rev TrendShrank
Revenue Consistency—
5 Years
—
-99.74%
40%
—
—
Never
—
5 Years
Score—
Net Growth-99.74%
Net Trend40%
Net Income Consistency—
Rev Growth—
Rev TrendNever
Revenue Consistency—
Explore the 2021 public Archive ranking →
Where Tenax Therapeutics Inc has ranked, year by year
Measure
Showing 1 year ranking history by HDB Score.
Has not reached the top 50 on HDB Score in any year we have ranked.
- TENX
2002: 80.0% · 2017: 99.8% · free through 2021 · longest runs
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-09-30 | $ 1.89 | — |
1 Year2025-09-30 | $ 7.61 | -75.16% |
5 Years2021-09-30 | $ 2.83K | -99.93% |
10 Years2016-09-30 | $ 74.08K | -100.00% |
20 Years2006-09-29 | $ 1000K | -100.00% |
30 Years1996-09-30 | $ 1000K | -100.00% |
All Time1997-01-02 | $ 1000K | -100.00% |
| Period | Last Price2026-09-30 | 1 Year2025-09-30 | 5 Years2021-09-30 | 10 Years2016-09-30 | 20 Years2006-09-29 | 30 Years1996-09-30 | All Time1997-01-02 |
|---|---|---|---|---|---|---|---|
| Price | $ 1.89 | $ 7.61 | $ 2.83K | $ 74.08K | $ 1000K | $ 1000K | $ 1000K |
| Return | — | -75.16% | -99.93% | -100.00% | -100.00% | -100.00% | -100.00% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
Reported in USD
| Year | |||
|---|---|---|---|
| TTM | $ 0.00 | -$ 64M | $ 117M |
| 2025 | $ 0.00 | -$ 52M | $ 97M |
| 2024 | $ 0.00 | -$ 17M | $ 94M |
| 2023 | $ 0.00 | -$ 7M | $ 9M |
| 2022 | $ 0.00 | -$ 11M | $ 2M |
| 2021 | $ 0.00 | -$ 32M | $ 5M |
| 2020 | $ 0.00 | -$ 9M | $ 6M |
| 2019 | $ 0.00 | -$ 8M | $ 5M |
| 2018 | $ 0.00 | -$ 6M | $ 12M |
| 2017 | $ 0.00 | -$ 8M | $ 7M |
| 2016 | $ 0.00 | -$ 43M | $ 13M |
| 2015 | $ 49.29K | -$ 14M | $ 20M |
| 2014 | $ 49.29K | -$ 14M | $ 58M |
| 2013 | $ 288.73K | -$ 19M | $ 58M |
| 2012 | $ 288.73K | -$ 19M | $ 6M |
| 2011 | $ 415.03K | -$ 15M | $ 3M |
| 2010 | $ 322.35K | -$ 10M | $ 632.71K |
| 2009 | $ 47.39K | -$ 10M | $ 2M |
| 2008 | -$ 6M | $ 4M | |
| 2007 | -$ 24.13K | -$ 3M | $ 940.24K |
| 2006 | -$ 25.63K | -$ 3M | $ 382.00 |
| 2005 | -$ 25.63K | -$ 2M | $ 588.76K |
| 2004 | -$ 2M | $ 1M | |
| 2003 | -$ 2M | $ 722.54K | |
| 2002 | -$ 3M | $ 524.43K | |
| 2001 | $ 1.00 | -$ 1M | $ 2M |
| 2000 | $ 1.00 | -$ 1M | $ 5M |
| 1999 | $ 1.00 | -$ 911.34K | $ 200K |
| 1998 | $ 1.00 | -$ 800K | $ 740.22K |
| IPO1997 | -$ 1M | $ 53.86K |
Tenax Therapeutics Inc fundamental performance
Between 2005 and 2025, revenue went from -$ 25.63K to $ 0.00 and net income went from -$ 2M to -$ 52M. Revenue increased in 3 of those 20 years; net income in 6.
Tenax Therapeutics Inc currently holds a 20-year HDB Score of 1.3 out of 10. How the HDB Score is calculated.
Membership
Continue TENX’s history
The public Archive runs through 2021. Membership adds recent and current rankings.
- Recent and current rankings across 3,814 companies
- Compare companies with the latest data
- Track your research shortlist in a portfolio
